FT836

· Medical College of Wisconsin

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for FT836, covering 2026-04-07 to 2026-04-14. Get the full timeline:

Most recent: Clinical Trial Update: FT836 CAR T-cell Therapy in Combination With Daratumumab in Patients With Relapsed and/or Refractory Multiple Myeloma [Phase 1]

See pricing